Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Self-Reporting Requirements Information Youll Provide: Current Measurements: Current weight (home scale) Height Recent blood pressure (if available) Medical History: Current health conditions Previous surgeries Medications and supplements Allergies Family health history Weight Loss History: Previous attempts Medications tried Results achieved Barriers encountered Lifestyle Factors: Diet patterns Exercise habits Stress levels Sleep quality Support system Honesty is Critical: Accurate information ensures safe prescribing Withholding information can lead to dangerous situations Providers make decisions based on what you report False information can result in inappropriate treatment Documentation That May Help (Not Always Required) Optional Supporting Documents: Recent lab work (CBC, metabolic panel, A1C, lipid panel) Blood pressure log Weight history documentation Medical records from primary care doctor List of current medications with doses These can strengthen your case but arent always necessary for approval
Phase 2 Type 2 Diabetes Trial The Lancet (2023) A parallel Phase 2 trial published in The Lancet assessed retatrutide in 281 participants with type 2 diabetes over 36 weeks
It is commonly used to prevent the active ingredient from sticking to the manufacturing equipment that presses the oral tablets into shape
Participants taking tirzepatide lost an average of 15.3% of their body weight after a year, while those on semaglutide lost about 8.3%
In March, another paper in JAMA Ophthalmology looked at optic nerve problems (NAION) among patients with Type 2 diabetes who took GLP-1 drugs
